Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)
|
5.08 -0.01 (-0.20%) 3:29EST Delayed |
|
|
|
- Compare SPPI with:
- View: Line | Candlestick
Company Profile
Spectrum Pharmaceuticals, Inc.
157 Technology Drive
Irvine, CA 92618
United States - Map
Phone: (949) 788-6700
Fax: (949) 788-6706
Website: www.spectrumpharm.com
State of incorporation: Delaware
CEO: Dr. Rajesh C. Shrotriya, M.D.
Employees: 84
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Major
an oncology-focused pharmaceutical company
A biopharmaceutical company, which develops and commercializing therapies with a focus mainly in the areas of hematology-oncology and urology.
Recent news for SPPI
-
Three Undervalued Cancer Drug Makers
Seeking Alpha - Mar 02 at 8:38AM (EST)
-
Market Watch for Spectrum Pharmaceuticals Inc. Issued by Beacon Equity
GlobeNewswire - Mar 02 at 6:50AM (EST)
-
Business Wire - Feb 25 at 7:00AM (EST)
-
Motley Fool - Feb 24 at 3:29PM (EST)
-
Motley Fool - Feb 17 at 3:12PM (EST)
-
[$$] Four Biotechs for the Near Term
Barrons.com - Feb 11 at 12:43PM (EST)
-
Biotech Deal-Making Crosses Borders as Capital Markets Slide
Seeking Alpha - Feb 09 at 4:32AM (EST)
-
EDGAR Online - Feb 08 at 4:31PM (EST)
-
Business Wire - Feb 05 at 7:00AM (EST)
-
Spectrum pays $30 million in licensing deal
AP - Feb 02 at 10:56AM (EST)
Member sentiment (?) Neutral
Top members owning SPPI
-
Top 51%
+0.10%
-
Top 36%
+2.00%
-
Top 2%
+3.40%
* Average monthly return vs. S&P 500